Edwards Lifesciences Corp

Connor, Clark & Lunn Investment Management Ltd. EW

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

687,091

Value ($000)

58,575

Weight

0.2%

2020 Q1 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	58,575	0.2%	687,091	12/31/2025
2025 Q3	11/13/2025	42,217	0.1%	542,841	9/30/2025
2025 Q2	8/7/2025	3,800	0.0%	48,589	6/30/2025
2024 Q4	2/10/2025	28,139	0.1%	380,103	12/31/2024
2024 Q3	11/8/2024	14,102	0.1%	213,700	9/30/2024
2024 Q2	8/9/2024	14,946	0.1%	161,804	6/30/2024
2024 Q1	5/9/2024	455	0.0%	4,761	3/31/2024
2023 Q4	2/9/2024	21,008	0.1%	275,517	12/31/2023
2023 Q3	11/13/2023	36,125	0.2%	521,429	9/30/2023
2023 Q2	8/10/2023	17,695	0.1%	187,588	6/30/2023
2023 Q1	5/10/2023	2,472	0.0%	29,885	3/31/2023
2022 Q4	2/10/2023	23,783	0.1%	318,765	12/31/2022
2022 Q3	11/10/2022	5,931	0.0%	71,774	9/30/2022
2022 Q2	8/5/2022	7,795	0.0%	81,970	6/30/2022
2022 Q1	5/12/2022	9,847	0.0%	83,644	3/31/2022
2021 Q3	11/12/2021	26,630	0.1%	235,227	9/30/2021
2021 Q2	8/12/2021	26,386	0.1%	254,763	6/30/2021
2021 Q1	5/13/2021	14,502	0.1%	173,389	3/31/2021
2020 Q4	2/16/2021	3,426	0.0%	37,553	12/31/2020
2020 Q3	11/12/2020	4,404	0.0%	55,175	9/30/2020
2020 Q1	5/13/2020	3,867	0.0%	20,500	3/31/2020